Abeona Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $5,420 | $0 | $400 | $0 |
Gross Profit | 1,720 | -488 | 300 | -815 |
EBITDA | -183,170 | -18,569 | 126,070 | -10,216 |
EBIT | -184,262 | -19,457 | 125,302 | -11,031 |
Net Income | -20,460 | -5,161 | 108,833 | -12,029 |
Net Change In Cash | 5,420 | 0 | 400 | 0 |
Free Cash Flow | -19,106 | -23,707 | -21,685 | -19,803 |
Cash | 78,437 | 83,222 | 163,535 | 15,936 |
Basic Shares | 66,135 | 54,242 | 66,640 | 49,779 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $5,820 | $0 | $3,500 | $1,414 |
Gross Profit | 4,288 | -2,907 | 1,895 | 964 |
EBITDA | -85,885 | -56,619 | -50,572 | -34,383 |
EBIT | -89,448 | -59,526 | -53,770 | -38,960 |
Net Income | 71,183 | -63,734 | -54,188 | -39,696 |
Net Change In Cash | 5,820 | 0 | 3,500 | 1,414 |
Free Cash Flow | -84,301 | -58,461 | -37,340 | -43,613 |
Cash | 78,437 | 23,357 | 14,473 | 14,217 |
Basic Shares | 66,135 | 41,048 | 21,380 | 7,862 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.36 |
2025-09-30 | -$0.10 |
2025-06-30 | $1.71 |
